Cibus (NASDAQ:CBUS) Given Buy Rating at HC Wainwright

HC Wainwright reiterated their buy rating on shares of Cibus (NASDAQ:CBUSFree Report) in a report published on Friday, Benzinga reports. They currently have a $25.00 price objective on the stock.

Cibus Stock Performance

Cibus stock opened at $20.38 on Friday. The firm has a market cap of $340.35 million, a P/E ratio of -1.56 and a beta of 1.90. The business’s fifty day moving average is $18.06 and its two-hundred day moving average is $16.57. Cibus has a 52 week low of $8.90 and a 52 week high of $38.85.

Hedge Funds Weigh In On Cibus

Institutional investors and hedge funds have recently bought and sold shares of the business. Gladius Capital Management LP acquired a new position in shares of Cibus during the fourth quarter valued at $56,000. Cerity Partners LLC acquired a new position in shares of Cibus during the second quarter valued at $120,000. Ground Swell Capital LLC acquired a new position in shares of Cibus during the second quarter valued at $125,000. UBS Group AG lifted its stake in shares of Cibus by 1,987.4% during the third quarter. UBS Group AG now owns 8,120 shares of the company’s stock valued at $148,000 after acquiring an additional 7,731 shares during the period. Finally, Regents of The University of California acquired a new position in shares of Cibus during the third quarter valued at $183,000. Institutional investors and hedge funds own 21.68% of the company’s stock.

Cibus Company Profile

(Get Free Report)

Cibus, Inc, a agricultural technology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.

Featured Articles

Receive News & Ratings for Cibus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cibus and related companies with MarketBeat.com's FREE daily email newsletter.